(410 ILCS 705/5-25) Sec. 5-25. Department of Public Health to make health warning recommendations. (a) The Department of Public Health shall make recommendations to the Department of Agriculture and the Department of Financial and Professional Regulation on appropriate health warnings for dispensaries and advertising, which may apply to all cannabis products, including item-type specific labeling or warning requirements, regulate the facility where cannabis-infused products are made, regulate cannabis-infused products as provided in subsection (e) of Section 55-5, and facilitate the Adult Use Cannabis Health Advisory Committee. (b) An Adult Use Cannabis Health Advisory Committee is hereby created and shall meet at least twice annually. The Chairperson may schedule meetings more frequently upon his or her initiative or upon the request of a Committee member. Meetings may be held in person or by teleconference. The Committee shall discuss and monitor changes in drug use data in Illinois and the emerging science and medical information relevant to the health effects associated with cannabis use and may provide recommendations to the Department of Human Services about public health awareness campaigns and messages. The Committee shall include the following members appointed by the Governor and shall represent the geographic, ethnic, and racial diversity of the State: (1) The Director of Public Health, or his or her designee, who shall serve as the |
|
(2) The Secretary of Human Services, or his or her designee, who shall serve as the
|
|
(3) A representative of the poison control center.
(4) A pharmacologist.
(5) A pulmonologist.
(6) An emergency room physician.
(7) An emergency medical technician, paramedic, emergency medical dispatcher, or other
|
|
(8) A nurse practicing in a school-based setting.
(9) A psychologist.
(10) A neonatologist.
(11) An obstetrician-gynecologist.
(12) A drug epidemiologist.
(13) A medical toxicologist.
(14) An addiction psychiatrist.
(15) A pediatrician.
(16) A representative of a statewide professional public health organization.
(17) A representative of a statewide hospital/health system association.
(18) An individual registered as a patient in the Compassionate Use of Medical Cannabis
|
|
(19) An individual registered as a caregiver in the Compassionate Use of Medical
|
|
(20) A representative of an organization focusing on cannabis-related policy.
(21) A representative of an organization focusing on the civil liberties of individuals
|
|
(22) A representative of the criminal defense or civil aid community of attorneys
|
| serving Disproportionately Impacted Areas.
|
|
(23) A representative of licensed cannabis business establishments.
(24) A Social Equity Applicant.
(25) A representative of a statewide community-based substance use disorder treatment
|
|
(26) A representative of a statewide community-based mental health treatment provider
|
|
(27) A representative of a community-based substance use disorder treatment provider.
(28) A representative of a community-based mental health treatment provider.
(29) A substance use disorder treatment patient representative.
(30) A mental health treatment patient representative.
(c) The Committee shall provide a report by September 30, 2021, and every year thereafter, to the General Assembly. The Department of Public Health shall make the report available on its website.
(Source: P.A. 101-27, eff. 6-25-19; 101-593, eff. 12-4-19; 102-1006, eff. 1-1-23.)
|